Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent manner

Metformin, a drug prescribed to treat type 2 diabetes, has been reported to possess antitumor activity via immunity activation. However, the influence of metformin on natural killer (NK) cells is not fully understood. Here, we investigated whether metformin exerts a potent anticancer effect by activ...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wenjiao Xia, Xin Qi, Mingfeng Li, Yu Wu, Lulu Sun, Xinglong Fan, Yuan Yuan, Jing Li
Format: article
Langue:EN
Publié: Taylor & Francis Group 2021
Sujets:
Accès en ligne:https://doaj.org/article/ffd0b0086e204654bfbb2c1ff0c79ebd
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!